
Cefmag S 250mg/125mg Injection
Marketer
Magma Allianz Laboratories Ltd
Salt Composition
Ceftriaxone (250mg) + Sulbactam (125mg)
Overview Cefmag S 250mg/125mg Injection
Cefmag S 250mg/125mg Injection, a dual-action medication, combats various bacterial infections. Its mechanism halts microbial proliferation and infection spread. Administration must always be under a doctor's guidance; missed doses should be avoided, and the full treatment course completed regardless of symptom improvement. Premature cessation can compromise its efficacy. Potential side effects include nausea, vomiting, diarrhea, and digestive upset. Severe or worsening side effects necessitate immediate medical attention. Allergic reactions (rash, itching, swelling, breathing difficulty) demand urgent medical help. Inform your physician about all current medications before starting this treatment. Pregnant or lactating individuals should consult their doctor prior to use. Alcohol consumption should be avoided due to potential increased drowsiness. While driving ability is usually unaffected, refrain from driving if drowsiness or dizziness occurs. Adequate rest, nutrition, and hydration are crucial for optimal recovery. Your doctor might order tests to monitor the medicine's impact on your system.
Uses of Cefmag S 250mg/125mg Injection
Infections caused by bacteria
Major Benefits of Cefmag S 250mg/125mg Injection:
This medication will be administered by your healthcare provider. Self-medication is strongly discouraged.
Common Side effects of Cefmag S 250mg/125mg Injection:
- Increased white blood cell count (eosinophils)
- Decreased white blood cell count (lymphocytes)
- Low blood platelets
- Rash
- Diarrhea
- Increased liver enzymes
- Injection site reactions (pain, swelling, redness)
How to use Cefmag S 250mg/125mg Injection:
The medication will be administered by your physician or registered nurse; self-medication is strictly prohibited.
How Cefmag S 250mg/125mg Injection works:
Ceftriaxone and Sulbactam, combined as Cefmag S 250mg/125mg Injection, offer a dual-action approach to bacterial infection. The antibiotic Ceftriaxone disrupts bacterial cell wall synthesis, hindering their growth and survival. Sulbactam, a beta-lactamase inhibitor, counteracts bacterial resistance mechanisms, thereby optimizing Ceftriaxone's effectiveness.
SAFETY ADVICE
AlcoholSAFE
There are no known adverse reactions from concurrent use of Cefmag S 250mg/125mg Injection and alcohol.
PregnancySAFE IF PRESCRIBED
The injectable medication Cefmag S (250mg/125mg) is typically deemed safe for use during gestation. Preclinical trials in animals revealed minimal or no harmful effects on fetal development; however, clinical data from human trials are scarce.
Breast feedingCAUTION
Administering Cefmag S 250mg/125mg Injection to breastfeeding mothers requires careful consideration. Discontinue breastfeeding throughout the mother's treatment course and until the medication is fully cleared from her system.
DrivingUNSAFE
The administration of Cefmag S 250mg/125mg Injection may induce drowsiness, visual disturbances, or dizziness. Refrain from operating a vehicle should these effects manifest.
KidneyCONSULT YOUR DOCTOR
Data regarding Cefmag S 250mg/125mg Injection use in individuals with renal impairment is scarce. Seek medical advice from your physician.
LiverCAUTION
Administering Cefmag S 250mg/125mg Injection requires careful consideration in individuals with severe hepatic impairment; dosage modification may be necessary. Physician consultation is advised. Dosage alteration for Cefmag S 250mg/125mg Injection is not suggested for patients exhibiting mild to moderate liver dysfunction.
What if you forget to take Cefmag S 250mg/125mg Injection :
Omitting a scheduled dose of Cefmag S 250mg/125mg Injection necessitates contacting your physician.
Facts to Know About Cefmag S 250mg/125mg Injection
| Label | Value |
|---|---|
| Developing Habits | No. |
| Treatment Category | Antimicrobial Agents |
